2022
Short-notice cancellations of laparoscopic permanent contraception
Masten M, Larrea N, Schultz C, Lazorwitz A. Short-notice cancellations of laparoscopic permanent contraception. Contraception 2022, 114: 49-53. PMID: 35545130, DOI: 10.1016/j.contraception.2022.04.013.Peer-Reviewed Original ResearchConceptsAcademic county hospitalSurgery cancellation ratesHigher cancellation rateCancellation ratePermanent contraceptionCounty HospitalContraceptive methodsAcademic tertiary care hospitalRetrospective cohort studyRetrospective chart reviewTertiary care hospitalPreferred contraceptive methodHealth care systemElectronic health recordsMost cancellationsChart reviewCohort studyCare hospitalSubsequent pregnancySurgery dateEffective contraceptionTubal sterilizationCommon reasonPatientsSurgery
2019
Pre- and post-operative counseling for women on hormonal contraceptives receiving sugammadex at an academic hospital
Lazorwitz A, Dindinger E, Aguirre N, Sheeder J. Pre- and post-operative counseling for women on hormonal contraceptives receiving sugammadex at an academic hospital. Journal Of Anesthesia 2019, 34: 294-297. PMID: 31865457, PMCID: PMC8496978, DOI: 10.1007/s00540-019-02725-2.Peer-Reviewed Original ResearchConceptsHormonal contraceptionDrug-drug interactionsUnintended pregnancyPost-operative counselingRetrospective chart reviewChart reviewRisk patientsHormonal contraceptivesColorado HospitalAcademic hospitalFDA labelContraceptive methodsSugammadexContraceptionPatientsWomenUnnecessary riskPregnancyHospitalCounselingExposureMedicationsContraceptivesProgestinsEstrogenRelationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
Lazorwitz A, Aquilante C, Dindinger E, Harrison M, Sheeder J, Teal S. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users. Obstetrics And Gynecology 2019, 134: 807-813. PMID: 31503152, PMCID: PMC6768730, DOI: 10.1097/aog.0000000000003452.Peer-Reviewed Original ResearchConceptsSerum etonogestrel concentrationsContraceptive implant usersEtonogestrel concentrationsOral contraceptive pillsRelated side effectsAbnormal bleedingSide effectsBleeding patternsContraceptive pillsContraceptive implantsBothersome bleedingImplant usersProspective cross-sectional studyReproductive-aged womenMultivariable logistic regressionHormonal contraceptive methodsCross-sectional studyDiscontinuation ratesEtonogestrel implantsPatient satisfactionPill prescriptionMedical recordsBleedingContraceptive methodsImplant use
2018
Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy
Lazorwitz A, Coleman-Minahan K, Teal S, Guiahi M. Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy. Journal Of Adolescent Health 2018, 63: 363-364. PMID: 30076014, DOI: 10.1016/j.jadohealth.2018.03.021.Peer-Reviewed Original ResearchConceptsContraceptive implantsPostpartum contraceptive methodAdverse pregnancy outcomesContraceptive implant useNeonatal outcomesPregnancy outcomesImplant exposureTeratogenic riskCase reportFavorable outcomeContraceptive methodsPharmacologic literatureClinical observationsImplant usePregnancyOutcomesImplantsNulligravidaEtonogestrelPatientsMore data
2014
Increasing Use of and Adherence to Long-Acting Reversible Contraceptive Methods in Adolescents and Young Adult Women
Lazorwitz A, Guiahi M. Increasing Use of and Adherence to Long-Acting Reversible Contraceptive Methods in Adolescents and Young Adult Women. Topics In Obstetrics & Gynecology 2014, 34: 1-7. DOI: 10.1097/01.pgo.0000442955.12502.a3.Peer-Reviewed Original Research